Ribomic Cash Flow Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Net Income	-1,144	-1,017	-1,023	-1,651	-1,683
Depreciation & Amortization	3	-	10	-	15
Loss (Gain) From Sale of Assets	5	2	40	3	48
Other Operating Activities	7	3	1	-	2
Change in Inventory	1	-1	-	-	-
Change in Accounts Payable	-7	14	-53	-35	112
Change in Other Net Operating Assets	25	3	93	-25	7
Operating Cash Flow	-1,110	-996	-932	-1,708	-1,499
Capital Expenditures	-10	-32	-22	-23	-10
Investment in Securities	300	100	200	300	700
Other Investing Activities	-1	-1	-1	-1	-1
Investing Cash Flow	289	67	177	276	689
Issuance of Common Stock	921	667	27	1,332	354
Other Financing Activities	-10	-	-	1	-
Financing Cash Flow	911	667	27	1,333	354
Foreign Exchange Rate Adjustments	-	-	2	21	18
Miscellaneous Cash Flow Adjustments	-	-	1	2	2
Net Cash Flow	90	-262	-725	-76	-436
Free Cash Flow	-1,120	-1,028	-954	-1,731	-1,509
Free Cash Flow Margin	-37333.33%	-51400.00%	-	-2663.08%	-1886.25%
Free Cash Flow Per Share	-22.56	-25.43	-26.73	-55.64	-53.70
Cash Income Tax Paid	2	1	1	1	1
Levered Free Cash Flow	-759.38	-704.25	-643.5	-1,211	-939.13
Unlevered Free Cash Flow	-759.38	-704.25	-643.5	-1,211	-939.13
Change in Working Capital	19	16	40	-60	119